«Killer Cells

Below is an extended Killer Cells patents listing. Click here to return to the Killer Cells main in depth entry.

Patents :
US Patent No.	Title
7411051	Antibodies to HDPPA04 polypeptide
7416887	Methods for use of MPL ligands with primitive human stem cells
7417045	Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity
7419660	Vaccines for treatment of lymphoma and leukemia
7419662	Methods of making chemokine alpha 3 antibodies
7419690	Method for enhancing proliferation of bone marrow cells or spleen cells with an ethanol-insoluble extract of dioscorea
7419799	Compositions and methods for the treatment of immune related diseases
7419805	Polynucleotides encoding S99T interferon gamma polypeptide variants and means of expression
7420033	Composition of lactoferrin related peptides and uses thereof
7420039	Individualized anti-cancer antibodies
7420040	Cytotoxicity mediation of cells evidencing surface expression of TROP-2
7416851	Method of diagnosis/prognosis of human chronic lymphocytic leukemia comprising the profiling of LPL/ADAM genes
7416727	Polypeptide variants with altered effector function
7416726	Enhancement of antibody-mediated immune responses
7411054	25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
7411056	Polynucleotides encoding cytokine receptor zalpha11
7413575	Nanofibrous biocomposite prosthetic vascular graft
7413733	Antigen transduced T cells used as a delivery system for antigens
7413756	Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
7413865	Diagnostic method for a transmissible spongiform encephalopathy or prion disease
7413866	Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
7413869	Method for determining potency of antigenic presenting cell based vaccines
7414032	Vaccine comprising a polynucleotide encoding an antigen recognized by a CD4.sup.+ helper T-cell and a polynucleotide encoding a tumor specific or associated antigen recognized by a CD8.sup.+ CTL
7414048	4,5-dihydro-isoxazole derivatives and their pharmaceutical use
7420041	Cytotoxicity mediation of cells evidencing surface expression of TROP-2
7420050	TGF-.beta.-specific covalently closed antisense molecule
7427494	Nucleic acid encoding cytokine receptor zcytor17
7427495	Methods of using Bcl-2 for the therapeutic treatment and prevention of diseases
7427600	Active agent delivery systems and methods for protecting and administering active agents
7427669	ULBP antibodies
7429376	Methods of screening for compounds that improve engraftment
7429489	Methods of controlling proliferation and differentiation of stem and progenitor cells
7429646	Antibodies to human tumor necrosis factor receptor-like 2
7431923	Cytotoxicity mediation of cells evidencing surface expression of CD63
7431932	Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
7431934	Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same
7427490	Diagnostic markers of stroke and cerebral injury and methods of use thereof
7425622	Antibodies against C3a receptor
7425620	Fc.gamma.RIIB-specific antibodies and methods of use thereof
7422746	Chemically programmable immunity
7423042	Compounds
7423194	Animal models for demyelination disorders
7425325	Cytokine zcytor17 ligand polypeptides
7425328	Tissue factor antibodies and uses thereof
7425548	Materials and methods for immune system stimulation
7425607	Compositions comprising a lung tumor antigen
7425610	Methods and materials relating to CD84-like polypeptides and polynucleotides
7425611	Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use
7425619	Fc.gamma.RIIB specific antibodies and methods of use thereof
7432059	Methods of identifying compounds that upmodulate T cell activation in the presence of a PD-1 mediated signal

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.